0.1% Accumulated Carton
2g 0.1% Accumulated Carton
PROTOPIC
tacrolimus ointment
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0469-5201
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TACROLIMUS (TACROLIMUS) TACROLIMUS 0.3 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
MINERAL OIL
PARAFFIN
PROPYLENE CARBONATE
PETROLATUM
WHITE WAX
Product Characteristics
Color Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# NDC Package Description Multilevel Packaging
1 0469-5201-30 30 g In 1 TUBE None
2 0469-5201-60 60 g In 1 TUBE None
3 0469-5201-11 100 g In 1 TUBE None
4 0469-5201-02 2 g In 1 TUBE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA050777 12/08/2000
PROTOPIC
tacrolimus ointment
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0469-5202
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TACROLIMUS (TACROLIMUS) TACROLIMUS 1 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
MINERAL OIL
PARAFFIN
PROPYLENE CARBONATE
PETROLATUM
WHITE WAX
Product Characteristics
Color Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# NDC Package Description Multilevel Packaging
1 0469-5202-30 30 g In 1 TUBE None
2 0469-5202-60 60 g In 1 TUBE None
3 0469-5202-11 100 g In 1 TUBE None
4 0469-5202-02 2 g In 1 TUBE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA050777 12/08/2000
Labeler - Astellas Pharma US, Inc. (605764828) Revised: 06/2009 Astellas Pharma US, Inc.
https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=16278